TCL Archive Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up December 26, 2014
TCL Archive Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial July 25, 2014